Clinical Trials
129 trialsORCHID
Fudan University
ARCADIAN
University of Oxford
PRECIOUS
Japan Breast Cancer Research Group
EORTC1616
The Netherlands Cancer Institute
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
The Cleveland Clinic
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
City of Hope Medical Center
Adaptive Therapy for Post-Second-Line Advanced Breast Cancer
Sun Yat-sen University
PemVin vs Vin in Previously Treated Metastatic Breast Cancer
Seoul National University Hospital
MOCCCA
Insel Gruppe AG, University Hospital Bern
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
University of Rochester
PADMA
GBG Forschungs GmbH
NORA
Spanish Lung Cancer Group
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer
University of Nebraska
DURATION
AIO-Studien-gGmbH
Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients
Spanish Breast Cancer Research Group
NVB Metro
Assistance Publique Hopitaux De Marseille
NARLAL
Odense University Hospital
VinMetAtezo
University Hospital, Brest
Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
Fudan University
Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
VIM
Wales Cancer Trials Unit
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients
Baylor Research Institute
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
Swiss Cancer Institute
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
Medstar Health Research Institute
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
Jonsson Comprehensive Cancer Center
SYSUCC-002
Sun Yat-sen University
A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer
Sun Yat-sen University
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
University of Maryland, Baltimore
Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations
Fudan University
CTC-TCM-FZ
Shanghai University of Traditional Chinese Medicine
Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy
Thoraxklinik-Heidelberg gGmbH
VinoMetro
Johannes Gutenberg University Mainz
Vinorelbine in Treating Patients With Metastatic Prostate Cancer
Swiss Cancer Institute
Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas
Children's National Research Institute
Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Swiss Cancer Institute
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
National Taiwan University Hospital
ONC-MANILA12
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Preoperative Herceptin and Navelbine for Breast Cancer
Dana-Farber Cancer Institute
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
UNC Lineberger Comprehensive Cancer Center
VIVOS
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)
SOLTI Breast Cancer Research Group
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)
Memorial Sloan Kettering Cancer Center
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Medical University of South Carolina
Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma
University of California, Irvine
RACCOSA
University Hospital, Limoges
ViGeM
Insel Gruppe AG, University Hospital Bern
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
University of Washington